Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Dynavax Technologies Stock News

DVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Trade with Public

Perks Trade with Public

$10.58

-0.32-2.94%

At close: -

$10.58

0.000.00%

After Hours: Jul 11, 4:06 PM EDT

Dynavax Technologies (DVAX) Forecast

News

Earnings Dynavax Technologies (DVAX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Dynavax Technologies Stock News | NASDAQ:DVAX | Benzinga

Get the latest news on Dynavax Technologies stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Dynavax Technologies performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, June 04, 2025

Dynavax Technologies Comments On A Report Pub...
Benzinga Newsdesk

Thursday, May 15, 2025

Deep Track Capital Issues Letter To Dynavax T...
Benzinga Newsdesk

Monday, May 12, 2025

Dynavax Defends Strategic Direction, Highligh...
Benzinga Newsdesk

Wednesday, May 07, 2025

Breaking Down Dynavax Technologies: 5 Analysts Share Their Views
Benzinga Insights
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Dynavax Technologies shares are trading lower...
Benzinga Newsdesk
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Vandana Singh

Tuesday, May 06, 2025

CORRECTION: Dynavax Technologies Q1 Adj. EPS ...
Benzinga Newsdesk
Earnings Scheduled For May 6, 2025
Benzinga Insights

Thursday, April 17, 2025

Where Dynavax Technologies Stands With Analysts
Benzinga Insights
Goldman Sachs Maintains Sell on Dynavax Techn...
Benzinga Newsdesk

Wednesday, April 16, 2025

Shares of vaccine stocks are trading lower af...
Benzinga Newsdesk

Friday, April 04, 2025

Reported Earlier, CenterPoint Energy Moves To...
Benzinga Newsdesk

Thursday, March 06, 2025

Dynavax Intends To Repurchase Approximately $...
Benzinga Newsdesk
Dynavax Has Entered Into Privately Negotiated...
Benzinga Newsdesk

Friday, February 21, 2025

Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
Citizens Capital Markets Maintains Market Out...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Thursday, February 20, 2025

Dynavax Technologies Q4 GAAP EPS $0.05 Beats ...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2025
Benzinga Insights

Wednesday, February 19, 2025

Dynavax Confirms That Deep Track Capital Subm...
Benzinga Newsdesk

Tuesday, February 11, 2025

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
Vandana Singh
Dynavax shares are trading lower after Goldma...
Benzinga Newsdesk
This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Goldman Sachs Downgrades Dynavax Technologies...
Benzinga Newsdesk

Tuesday, January 14, 2025

HC Wainwright & Co. Maintains Buy on Dynavax ...
Benzinga Newsdesk

Monday, January 13, 2025

Dynavax Prelim. 2024 HEPLISAV-B Net Product R...
Benzinga Newsdesk

Monday, November 11, 2024

Dynavax Announces $100M Accelerated Share Rep...
Benzinga Newsdesk

Friday, November 08, 2024

Dynavax Technologies shares are trading highe...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Thursday, November 07, 2024

Dynavax Launches $200M Share Buyback Program ...
Benzinga Newsdesk
Dynavax Technologies Q3 2024 GAAP EPS $0.12 B...
Benzinga Newsdesk

Wednesday, November 06, 2024

Insights into Dynavax Technologies's Upcoming Earnings
Benzinga Insights

Tuesday, October 29, 2024

Dynavax Adopts Limited-Duration Stockholder R...
Benzinga Newsdesk

Tuesday, October 15, 2024

HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Thursday, August 08, 2024

Assessing Dynavax Technologies: Insights From 4 Financial Analysts
Benzinga Insights
Goldman Sachs Maintains Neutral on Dynavax Te...
Benzinga Newsdesk

Wednesday, August 07, 2024

HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Tuesday, August 06, 2024

Dynavax Reaffirms 2024 HEPLISAV-B Net Product...
Benzinga Newsdesk
Dynavax Technologies Q2 2024 GAAP EPS $0.08 B...
Benzinga Newsdesk

Friday, August 02, 2024

Dynavax Reappoints Kelly MacDonald As CFO Eff...
Benzinga Newsdesk

Friday, June 28, 2024

HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Thursday, June 27, 2024

Dynavax Initiates Phase 1/2 Study Of Novel Sh...
Benzinga Newsdesk

Tuesday, May 14, 2024

HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
Vandana Singh
FDA Issued Complete Response Letter To Dynava...
Benzinga Newsdesk

Thursday, May 09, 2024

HC Wainwright & Co. Reiterates Buy on Dynavax...
Benzinga Newsdesk

Wednesday, May 08, 2024

Dynavax shares are trading lower after the co...
Benzinga Newsdesk
Dynavax Reaffirms Full Year 2024 Financial Gu...
Benzinga Newsdesk
Dynavax Technologies Q1 2024 GAAP EPS $(0.07)...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved